Fig. 7From: Lysine lactylation (Kla) might be a novel therapeutic target for breast cancerImmunotherapy analysis on basis of Kla. A-E, CCR7 and IGFBP6 were positively related to immunotherapy response, while NDUFAF6, OVOL1 and SDC1 were opposite. F, the correlation between Kla and immune checkpoint expressionBack to article page